HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Policy

Supreme Court questions how far generics makers can go with 'skinny label' drugs

WASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the pharmaceutical industry. In its final argument scheduled for this term, the high court on Wednesday ...

By Endpoints News · Apr 30, 2026 · via Endpoints News
Supreme Court questions how far generics makers can go with 'skinny label' drugs

Image: Endpoints News

This is an aggregated industry headline. Read the full story at Endpoints News →

Tags
policyformat:headlineheadlineEndpoints News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
Purdue Pharma’s Dissolution Approved, Closing Chapter in OxyContin Legal Case
PolicyBriefing
Purdue Pharma’s Dissolution Approved, Closing Chapter in OxyContin Legal Case
A judge approved Purdue Pharma’s criminal sentence, clearing the way for the company’s dissolution after years…
May 1, 2026
PolicyAJMC ↗
…
Apr 30, 2026
STAT+: FDA wants to exclude weight loss drugs from a compounding list
PolicySTAT News ↗
STAT+: FDA wants to exclude weight loss drugs from a compounding list
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's n…
Apr 30, 2026